Abcam Plc (ABC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12164
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products are used by life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.

Abcam Plc (ABC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abcam Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abcam Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abcam Plc, Medical Equipment, Deal Details 10
Venture Financing 10
Firefly BioWorks Raises USD0.8 Million in Venture Financing 10
Partnerships 11
Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 11
Abcam and Molecular Devices Enter into Partnership 12
TTP LabTech and Abcam Enter into Partnership 13
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 14
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 15
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 16
Abcam Enters into Licensing Agreement with Roche 17
Acquisition 18
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 18
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 19
Abcam Plc – Key Competitors 20
Abcam Plc – Key Employees 21
Abcam Plc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Financial Announcements 24
Sep 10, 2018: Abcam: Preliminary results 2018 24
Mar 05, 2018: Abcam: Interim results for the six months ended 31 December 2017 26
Sep 11, 2017: Abcam: Double-digit earnings growth enabling investment for sustained future growth 27
Corporate Communications 28
Oct 30, 2018: Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development 28
Jun 18, 2018: Abcam Appoints Peter Allen As Chairman 29
Nov 15, 2017: ABCAM: Result of AGM and Directorate Change 30
Oct 11, 2017: Abcam: Directorate Change – Chairman 31
Product News 32
Feb 07, 2018: New CatchPoint SimpleStep ELISA fluorescent 90-minute assay 32
Oct 23, 2017: New multiplex assay technology for RNA and protein quantitation 33
Other Significant Developments 34
Apr 26, 2018: Abcam And Shuwen Biotech Sign Strategic MoU To Establish Global Alliance For Companion Diagnostic (CDx) Kit Development 34
Jul 27, 2017: Abcam: Pre-Close Period Update 35
May 18, 2017: Abcam Makes Final Performance-Based AxioMx Milestone Payment 36
Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Abcam Plc, Medical Equipment, Key Facts, 2018 2
Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abcam Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abcam Plc, Deals By Market, 2012 to YTD 2018 8
Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Firefly BioWorks Raises USD0.8 Million in Venture Financing 10
Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 11
Abcam and Molecular Devices Enter into Partnership 12
TTP LabTech and Abcam Enter into Partnership 13
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 14
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 15
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 16
Abcam Enters into Licensing Agreement with Roche 17
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 18
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 19
Abcam Plc, Key Competitors 20
Abcam Plc, Key Employees 21
Abcam Plc, Subsidiaries 22

List of Figures
Abcam Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abcam Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abcam Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abcam Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abcam Plc (ABC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eurobank Ergasias SA:戦略・SWOT・企業財務分析
    Eurobank Ergasias SA - Strategy, SWOT and Corporate Finance Report Summary Eurobank Ergasias SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Omega Pharma NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • Parexel International Corp:医療機器:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • TriGranit Corporation:企業の戦略・SWOT・財務情報
    TriGranit Corporation - Strategy, SWOT and Corporate Finance Report Summary TriGranit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lekoil Ltd (LEK):企業の財務・戦略的SWOT分析
    Summary Lekoil Ltd (Lekoil) is an oil and gas exploration and production company with interests in Nigeria and Namibia. The company owns oil and gas exploration and production properties such as Otakikpo marginal field, Nigeria Dahomey Basin OPL310 and Nigeria Dahomey Basin OPL 325 in Nigeria, and B …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Galen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angi …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …
  • Grupo Bimbo, S.A.B. de C.V. (BIMBOA):企業の財務・戦略的SWOT分析
    Grupo Bimbo, S.A.B. de C.V. (BIMBOA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • City Holding Co (CHCO):企業の財務・戦略的SWOT分析
    City Holding Co (CHCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Specialty Fashion Group Ltd (SFH):企業の財務・戦略的SWOT分析
    Specialty Fashion Group Ltd (SFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • The Interpublic Group of Companies, Inc. (IPG):企業の財務・戦略的SWOT分析
    The Interpublic Group of Companies, Inc. (IPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers DRP platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurpo …
  • Exelixis Inc (EXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Croda International Plc (CRDA):企業の財務・戦略的SWOT分析
    Croda International Plc (CRDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆